All data are based on the daily closing price as of April 10, 2026
k

Kaneka

4118.TSE
31.86 USD
-0.51
-1.58%

Overview

Last close
31.86 usd
Market cap
1.92B usd
52 week high
33.80 usd
52 week low
21.82 usd
Target price
31.2 usd

Valuation

P/E
12.3917
Forward P/E
8.9047
Price/Sales
0.3885
Price/Book Value
0.6417
Enterprise Value
2.98B usd
EV/Revenue
0.5869
EV/EBITDA
5.4159

Key financials

Revenue TTM
5.04B usd
Gross Profit TTM
1.40B usd
EBITDA TTM
476.79M usd
Earnings per Share
2.61 usd
Dividend
0.94 usd
Total assets
6.09B usd
Net debt
1.05B usd

About

Kaneka Corporation engages in the manufacture and sale of polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan and internationally. It provides impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, and biodegradable polymer, as well as engineering resin for injection molding, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; and organic EL lighting panels, lithium-ion battery, and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. Additionally, it provides dairy products, yogurt, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, which include coenzyme, probiotics, and dietary ingredients, as well as fertilizers. The company was incorporated in 1949 and is headquartered in Tokyo, Japan.
  • Symbol
    4118.TSE
  • Exchange
    TSE
  • Isin
    JP3215800008
  • Country
    Japan
  • Sector
    Basic Materials
  • Industry
    Specialty Chemicals
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.kaneka.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top